Écrit par EMBO | 04 Mai 2013

HEIDELBERG, 3 May 2013 – An international group of leading stem cell researchers has issued a statement that specifies concerns about the development and use of unproven stem cell therapies. The commentary is published online today in The EMBO Journal ahead of a debate in the Italian parliament on whether to change a recent law that allows certain untested stem cell therapies to be used...

Écrit par Wiley | 03 Mai 2013

The LAP-BAND® weight loss procedure is safe and effective in an expanded group of patients, not just in people who are morbidly obese. This conclusion is reported in a new study published in the scientific journal Obesity. The findings indicate that the procedure may help to intervene before obesity becomes life threatening to patients.

In 2001 the LAP-BAND® adjustable gastric banding...

Écrit par Wiley | 30 Avril 2013

A study published in Liver Transplantation, a journal of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, reports that donor mortality is about 1 in 500 donors with living donor liver transplantation (LDLT). Research of transplant centers around the world found that those with more experience conducting live donor procedures...

Écrit par Novozymes | 26 Avril 2013

COPENHAGEN, DENMARK – April 25, 2013 - Novozymes, the world leader in bioinnovation and industrial enzymes, today reported a first quarter of 2013 in line with expectations. Organic sales growth was 5% (4% DKK, 5% LCY) compared with Q1 2012. EBIT grew by 4%, and the EBIT margin was 24.9% – on par with the first quarter of 2012. The outlook for full-year 2013 sales growth in DKK...